Skip to content
10-Q

Quarterly Report

Aura Biosciences, Inc. AURA

0000950170-25-071907

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 9, 2025 50.27M sh
Current Liabilities Q1 2025 · Mar 31, 2025 $12.16M
Current Liabilities Q1 2025 · Dec 31, 2024 $14.91M
Total Liabilities Q1 2025 · Mar 31, 2025 $27.44M
Total Liabilities Q1 2025 · Dec 31, 2024 $30.53M
Current Assets Q1 2025 · Mar 31, 2025 $134.52M
Current Assets Q1 2025 · Dec 31, 2024 $160.62M
Total Assets Q1 2025 · Mar 31, 2025 $155.4M
Total Assets Q1 2025 · Dec 31, 2024 $182.5M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $31.69M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $26.28M
Shares Diluted Q1 2025 · Mar 31, 2024 49.45M sh
Capex Q1 2025 · Mar 31, 2024 $88K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$24.45M
Stockholders Equity Q1 2025 · Mar 31, 2024 $208.78M
Stockholders Equity Q1 2025 · Dec 31, 2023 $225.85M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.40
Eps Basic Q1 2025 · Mar 31, 2024 −$0.40
Sga Expense Q1 2025 · Mar 31, 2024 $5.26M
Rd Expense Q1 2025 · Mar 31, 2024 $17.05M
Net Income Q1 2025 · Mar 31, 2024 −$19.71M
Operating Income Q1 2025 · Mar 31, 2024 −$22.31M